Lenvatinib - CaLiGraph

CaLiGraph

Property	Value
rdf:type	Urea owl:NamedIndividual Chloroarene Orphan drug Protein kinase inhibitor Carboxamide Cyclopropane Drug granted breakthrough therapy designation
rdfs:label	Lenvatinib
owl:sameAs	dbr:Lenvatinib
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Category:Chloroarenes http://en.wikipedia.org/wiki/Category:Orphan_drugs http://en.wikipedia.org/wiki/Category:Ureas http://en.wikipedia.org/wiki/Anti%E2%80%93vascular_endothelial_growth_factor_therapy http://en.wikipedia.org/wiki/Protein_kinase_inhibitor http://en.wikipedia.org/wiki/List_of_drugs_granted_breakthrough_therapy_designation http://en.wikipedia.org/wiki/Renal_cell_carcinoma http://en.wikipedia.org/wiki/Category:Protein_kinase_inhibitors http://en.wikipedia.org/wiki/Category:Carboxamides http://en.wikipedia.org/wiki/Category:Cyclopropanes
skos:prefLabel	Lenvatinib
skos:altLabel	Lenvanix Lenvatinib + Pembrolizumab Lenvema lenvatinib
clgo:alternativeName	Lenvima, others
clgo:bioavailability	85.0
clgo:casNumber	417716-92-8
clgo:chEBI	85994
clgo:chEMBL	1289601
clgo:drugbank	DB09078
clgo:fdaUniiCode	EE083865G2
clgo:kegg	D09919 D09920
clgo:pubchem	9823820
is clgo:product of	Beacon Pharmaceuticals Eisai (company)

About: clgr:Lenvatinib